Companies in the therapeutics sector developing innovative solutions and technologies.
Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.
Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.
N-Zyme Biomedical develops pepsin inhibitor therapies and drug formulations for reflux diseases such as LPR and GERD.
Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.
Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis.
ClearSight Therapeutics is a biotech firm focusing on creating pharmaceutical and medical device solutions for ophthalmology.
Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.
Peptaris develops AI-driven platforms for discovering and designing therapeutic peptides.
Biolevate provides an AI platform for life sciences teams to manage regulated operations through evidence-driven, auditable workflows.
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.
Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.
Piomic Medical develops regenerative medical devices using optical and magnetic stimulation to support tissue regeneration.
Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.
Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.
HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.
RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.
Aitiologic is an Austrian precision medicine firm that creates AI-powered solutions for early disease identification and tailored therapy.
ReEmerge is a medical technology company that specializes in cognitive network restoration therapy.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.
Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked